Medtronic carries the broadest product line in medical technology, spanning pacemakers and defibrillators, spinal implants, insulin pumps, surgical tools and stroke care. Cardiovascular devices remain the historic core, dating to the company's founding in a Minneapolis garage in 1949, when it built the first wearable pacemaker. Scale brings reach into hospitals worldwide but also conglomerate complexity, and management continually prunes the portfolio. Registered in Ireland since a 2015 acquisition, Medtronic pairs medtech innovation with a long dividend growth streak.